CNS Pharmaceuticals Inc (CNSP) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	2.20M	3.17M	3.54M	1.20M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.06M	2.82M	1.43M	1.50M
Operating expense	3.25M	5.99M	4.98M	2.70M
Total operating expenses	3.25M	5.99M	4.98M	2.70M
Operating income	-3.25M	-5.99M	-4.98M	-2.70M
Other non operating income	-	-2.56K	-	-
EBT including unusual items	-3.22M	-5.96M	-4.94M	-2.59M
EBT excluding unusual items	-3.22M	-5.96M	-4.94M	-2.59M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-3.22M	-5.96M	-4.94M	-2.59M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	37.02K	35.60K	44.27K	116.00K
Interest expense	-2.12K	-2.72K	-6.11K	-4.00K
Net interest expenses	34.91K	32.88K	38.16K	112.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-3.25M	-5.99M	-4.97M	-2.69M
Gain or loss from assets sale	-	2.56K	-	-

Finance